Cite
MLA Citation
Hoda Pourhassan et al.. “High prevalence and inferior long‐term outcomes for TP53 mutations in therapy‐related acute lymphoblastic leukemia.” American journal of hematology, vol. 97, no. 5, 2022, pp. E171–E173. http://access.bl.uk/ark:/81055/vdc_100153440386.0x000013